Skip to main content
. 2015 Jul 15;121(19):3481–3490. doi: 10.1002/cncr.29422

Figure 1.

Figure 1

(A) Response relative to time on CC‐223 treatment and (B) best percentage change from baseline in total length of target lesions were evaluated in 28 and 19 patients, respectively. Abbreviations: CRC, colorectal carcinoma; GBC, glioblastoma multiforme; HCC, hepatocellular carcinoma; MM, multiple myeloma; NET, (gastrointestinal) neuroendocrine tumor (of nonpancreatic origin); NSCLC, non–small cell lung cancer; RCC, renal cell carcinoma.